Chimeric Antigen Receptor (CAR) therapy is a groundbreaking form of immunotherapy that harnesses the power of the patient's own immune system to target and destroy cancer cells. In CAR therapy, a patient's T cells are genetically engineered to express special receptors on their surface. These receptors, known as CARs, enable the T cells to recognize and bind to specific proteins on the surface of cancer cells, leading to their destruction.
